Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
Sponsor: Beijing Friendship Hospital
Summary
This study aimed to investigate the efficacy and safety of Carrimycin tablets in hemophagocytic lymphohistiocytosis patients with Carbapenem-resistant infections.
Official title: Clinical Study on the Efficacy and Safety of Carrimycin Tablets in Hemophagocytic Lymphohistiocytosis Patients With Carbapenem-resistant Infections
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2023-08-30
Completion Date
2026-12-30
Last Updated
2023-08-14
Healthy Volunteers
No
Interventions
Carrimycin tablets
Carrimycin tablets are administered 400mg a day orally for 7 days.
Locations (1)
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China